Opinion / #ASEAN

Mask_Malaysia_Medical_Innovation
Hepatitis C treatment is no longer prohibitively expensive in the Global South because Malaysia, Thailand, Egypt and the Drugs for Neglected Diseases initiative developed ravidasvir – a low-cost antiviral. Such breakthroughs are possible for other neglected diseases if low- and middle-income countries agree to act collectively.

全部ASEAN Opinion

8 四月 2025

7 三月 2025

6 三月 2025

27 一月 2025

7 一月 2025

27 十二月 2024

13 十二月 2024

27 十一月 2024

25 十一月 2024

18 十一月 2024

4 九月 2024

23 八月 2024

1 八月 2024

20 六月 2024

3 六月 2024

10 五月 2024

最多人阅读

leaf background pattern

改革创新,实现可持续性 加入Ecosystem →